Sources

13 Total Sources

Bempikibart Cuts Severe Alopecia Score 35.3% at 36 Weeks as 40% Regrow Hair

Center67%

Right33%

TradingView20h ago

Bempikibart Shows Significant Hair Regrowth, Safety in Severe Alopecia Areata at 36 Weeks

StockTitan20h ago

Q32 Bio posts 36-week Phase 2a AA data for bempikibart | QTTB Stock News

discover-pharma.com20h ago

Q32 Bio reports positive Phase 2 alopecia areata trial results for bempikibart – Discover Pharma

Seeking Alpha13h ago

Q32 Bio: 'Strong Buy' Solid Bempikibart SIGNAL-AA Study Data And Catalysts | Seeking Alpha

top1markets.com5h ago

QTTB Stock Soars 68%: Bempikibart Alopecia Data Decoded | TOPONE Markets

pharmacally.com14h ago

Q32 Bio Reports Positive Phase 2 Results for Bempikibart in Alopecia Areata - Pharmacally

Tech Times19h ago

Alopecia Areata Drug Holds Hair Regrowth After Patients Stop Taking It

MD Magazine20h ago

SIGNAL-AA: Bempikibart Effective for Alopecia Areata at 36 Weeks | HCPLive

Minichart20h ago

Q32 Bio's Bempikibart Shows Robust 36-Week Efficacy and Safety in Severe Alopecia Areata Phase 2a SIGNAL-AA Trial Results – Minichart

dermatologytimes.com20h ago

Bempikibart Shows Positive Phase 2a Results in Alopecia Areata | Dermatology Times

Q32 Bio Inc. reports successful 36-week results in bempikibart trial for severe alopecia areata

Q32 Bio Reports Positive Results For Hair Loss Treatment; Stock Up Over 150% In Four Months

PR Newswire22h ago

Q32 Bio Announces Positive 36-Week Topline Results from Part B of the SIGNAL-AA Clinical Trial of Bempikibart in Alopecia Areata